UnknownNot Applicable

Gut Microbiota in the Progression of Alpha-synucleinopathies

Hong Kong490 participantsStarted 2022-02-01

Plain-language summary

The aim of this study is to correlate baseline gut microbiota features and the progression of neurodegeneration in the established cohort of patients with early Parkinson's disease.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * recruit from the subjects who completed the baseline study Exclusion Criteria: * The use of probiotics or antibiotics within three months prior to sample collection; * Pre-existing gastrointestinal diseases, such as inflammatory bowel disease. * Not capable of giving informed consent for participation of the study.

What they're measuring

Composition of gut microbiota

Timeframe: 2 years

Trial details

NCT IDNCT05353868

SponsorChinese University of Hong Kong

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-06-30

View on ClinicalTrials.gov More REM Sleep Behavior Disorder trials